Press-release for stocks publishing date 2021 - 07

Prices are updated after-hours

BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
Published: 2021-07-19 (Crawled : 12:15) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M

| -11.21% | O: -0.68% H: 0.41% C: -0.31%
GILD | $66.94 -0.55% -0.55% 5.3M

| -1.69% | O: 0.2% H: 0.67% C: -0.55%
BNTX | $86.42 0.09% 0.09% 1.2M

| -61.64% | O: 1.3% H: 8.47% C: 6.42%
therapy

56%

44%

INVO | $1.76 131.58% 56.82% 230M

SINT | $0.0365 59.39% 37.26% 470M

WISA 4 | $9.19 50.66% 33.7% 65M

EDBL | News | $6.73 47.91% 32.39% 13M

GCTK | $0.715 36.27% 26.62% 640K

TCON | $2.33 36.26% 26.61% 2M

TIRX | $0.48 6.43% 24.58% 4.8M

KZIA | $0.38 30.58% 23.42% 300K

VNDA | News | $5.23 29.14% 22.56% 24M

ATNF | $1.91 29.05% 22.51% 310K

Save your searches and get alerts when important news are released.